Jupiter Asset Management’s Aurinia Pharmaceuticals AUPH Stock Holding History

Jupiter Asset Management’s Portfolio AUPH Stock Details AUPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$18.6M	Buy	1,094,475 +291,056	+36%	+$4.65M	0.09%	246
2026 Q1	$11.9M	Sell	803,419 -96,064	-11%	-$1.4M	0.06%	262
2025 Q4	$14.3M	Buy	899,483 +75,904	+9%	+$1.08M	0.11%	191
2025 Q3	$9.1M	Sell	823,579 -110,283	-12%	-$1.2M	0.08%	229
2025 Q2	$7.91M	Buy	933,862 +181,093	+24%	+$1.45M	0.07%	239
2025 Q1	$6.05M	Buy	+752,769	New	+$6.1M	0.06%	261
2024 Q3	–	Sell	-158,497	Closed	-$905K	–	410
2024 Q2	$905K	Sell	158,497 -88,555	-36%	-$466K	0.01%	340
2024 Q1	$1.24M	Buy	247,052 +43,366	+21%	+$294K	0.01%	354
2023 Q4	$1.83M	Buy	203,686 +172,411	+551%	+$1.42M	0.02%	343
2023 Q3	$243K	Sell	31,275 -67,415	-68%	-$659K	﹤0.01%	460
2023 Q2	$955K	Buy	+98,690	New	+$1.02M	0.01%	433

Other funds holding AUPH

TCM

Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

NMC

NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Jupiter Asset Management's AUPH Position: Q2 2026 in Review

Jupiter Asset Management increased its Aurinia Pharmaceuticals (AUPH) stake by 36% in Q2 2026, buying an estimated $4.65M and bringing the position to 1,094,475 shares worth $18.6M. The position accounts for 0.09% of the portfolio, ranked #246.

Jupiter Asset Management first reported a position in AUPH in Q2 2023 and has held it in 11 quarters since. 281 funds tracked by Wall St. Rank hold AUPH as of Q2 2026.

Jupiter Asset Management held 1,094,475 shares of Aurinia Pharmaceuticals worth $18.6M as of Q2 2026.
Jupiter Asset Management bought 291,056 Aurinia Pharmaceuticals shares in Q2 2026, an estimated $4.65M.
Aurinia Pharmaceuticals made up 0.09% of Jupiter Asset Management's portfolio in Q2 2026, its #246 holding.
Jupiter Asset Management first reported a position in Aurinia Pharmaceuticals in Q2 2023 and has held it in 11 quarters since.
281 funds tracked by Wall St. Rank held Aurinia Pharmaceuticals as of Q2 2026.

Based on Jupiter Asset Management's 13F filing for Q2 2026, filed 10 Aug 2026.